% Expired Patents = 37.5

Forward Citations = 71

Loading Chart...

4 inventors (with patents filed for the assignee):

Arasteh Ari Azhir (8 out of 14 patents)

William Allen Boulanger (5 out of 15 patents)

Michael S McGrath (3 out of 26 patents)

4. Clifford A Lingwood (2 out of 18 patents)

8 patents: Sort by Forward Citations

1. 9839650 - Chlorite formulations, and methods of preparation and use thereof (2017-12-12),

2. 9579346 - Treatment of macrophage-related disorders (2017-02-28),

3. 9266734 - Chlorite formulations and methods of preparation and use thereof (2016-02-23),

4. 9023845 - Compositions and methods for treating lysosomal disorders (2015-05-05),

5. 8501244 - Chlorite formulations and methods of preparation and use thereof (2013-08-06),

6. 8252789 - Compositions and methods for treating lysosomal disorders (2012-08-28),

7. 8231856 - Chlorite formulations and methods of preparation and use thereof (2012-07-31),

8. 8067035 - Chlorite formulations, and methods of preparation and use thereof (2011-11-29),

Company Overview

Neuraltus Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing novel therapeutics for neurodegenerative diseases. The company's lead candidate, NP001, is being investigated for the treatment of Amyotrophic Lateral Sclerosis (ALS) and other disorders. Neuraltus is committed to advancing innovative treatments to improve the lives of patients with serious neurological conditions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

8 Patents

#11 in San Bruno, CA

#8,540 in California

#35,924 in US

San Bruno, CA, United States of America

Neuraltus Pharmaceuticals, Inc.

Forward Citations = 71

4 inventors:

Arasteh Ari Azhir (8 out of 14 patents)

William Allen Boulanger (5 out of 15 patents)

Michael S McGrath (3 out of 26 patents)

4. Clifford A Lingwood (2 out of 18 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Neuraltus Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/neuraltus-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]